HomeInvestingEarningsJohnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways

Johnson & Johnson (JNJ) Shockwave Deal & Earnings Takeaways

CFRA views the newly announced $13.1B Johnson & Johnson (JNJ) shockwave deal as positive. David Toung and Sel Hardy discuss the takeaways from Johnson & Johnson’s earnings. The CFRA analyst also notes that they think shares have been under pressure to news that its cough syrup has to be recalled in several African countries. Tune in to find out more about the stock market today.

Trading 360

16 Apr 2024

SHARE

ON AIR
8:00 am
Morning Trade Live
12:00 am
Trading 360
REPLAY
1:00 am
Fast Market
REPLAY
2:00 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:30 am
Gamma On
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Inside the Mind of a Trader
REPLAY
education
6:00 am
Inside the Mind of a Trader
REPLAY
6:30 am
Market Overtime
REPLAY
7:00 am
Futures
ON AIR
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Gamma On
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Gamma On
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor